Predictably, TIGIT expression has mostly been found in CD3+ tumor-infiltrating lymphocytes (TILs) and peritumoral lymphocytic infiltrates, given its physiological role, highlighting an “exhausted” T-cell phenotype in a consistent proportion of cancer microenvironments. This evidence concerns the gene TIGIT and neoplasm.